Skip to content

Clinical trials

Observational Schizophrenia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Observational Country / region: United Kingdom Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20172
20182
20202
20223
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
King's College London2
Akrivia Health1
Daniel Benjamin1
Eisai Co., Ltd.1
Hoffmann-La Roche1
Icahn School of Medicine at Mount Sinai1
Janssen-Cilag International NV1
Manchester Academic Health Science Centre1
Momentum Data1
Norfolk and Suffolk NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia17
Psychotic Disorders8
Bipolar Disorder7
Mental Disorders4
Anxiety Disorders3
Depressive Disorder3
Inflammation2
Mood Disorders2
Personality Disorders2
Adenoviridae Infections1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.